COMMUNIQUÉS West-GlobeNewswire
-
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets
06/01/2026 -
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
06/01/2026 -
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
06/01/2026 -
Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry
06/01/2026 -
LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.
06/01/2026 -
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
06/01/2026 -
Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development
06/01/2026 -
Prestigious Research University Integrates SteraMist Hybrid System for Advanced Medical Product Sterilization
06/01/2026 -
Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers
06/01/2026 -
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference
06/01/2026 -
Medical AI Expert Wido Menhardt Joins FemPulse Scientific Advisory Board
06/01/2026 -
Visory Health Named to Inc.’s Best in Business for Excellence in Social Good
06/01/2026 -
2026 New Year’s Greetings from the CEO
06/01/2026 -
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
J-Star Announces Strategic Plan to Exit China and Accelerate Expansion in the United States
06/01/2026 -
Clever Care Health Plan and CareMore Health Launch New Partnership to Expand Access to Care in Southern California
06/01/2026 -
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study
06/01/2026 -
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
06/01/2026 -
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
06/01/2026
Pages